Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acitretin: optimal dosing strategies.

M R Ling1

  • 1MedaPhase, Inc., 393 Mill Creek Bend NE, Atlanta, GA 30307, USA.

Journal of the American Academy of Dermatology
|August 25, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypochlorous acid regulates neutrophil extracellular trap release in humans.

Clinical and experimental immunology·2012
Same author

Topical tacrolimus and pimecrolimus: future directions.

Seminars in cutaneous medicine and surgery·2002
Same author

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy.

Journal of the American Academy of Dermatology·2001
Same author

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.

Journal of the American Academy of Dermatology·1998
Same author

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.

Journal of the American Academy of Dermatology·1998
Same author

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.

Journal of the American Academy of Dermatology·1998

Acitretin effectively treats psoriasis, especially pustular and erythrodermic types. Optimal dosing involves a gradual increase to balance effectiveness and minimize side effects for individual plaque-type psoriasis patients.

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Acitretin is a synthetic oral retinoid used for psoriasis treatment.
  • Its efficacy varies by psoriasis subtype and treatment approach (monotherapy vs. combination).

Purpose of the Study:

  • To outline the effective dosing strategies for acitretin in psoriasis management.
  • To emphasize balancing therapeutic response with minimizing adverse effects.

Main Methods:

  • Review of dose-response studies for acitretin.
  • Analysis of efficacy and side effect profiles across different psoriasis types.
  • Evaluation of dose-escalation strategies.

Main Results:

  • Acitretin monotherapy is most effective for pustular and erythrodermic psoriasis.

Related Experiment Videos

  • Combination therapy enhances acitretin's effectiveness for plaque-type psoriasis.
  • Dose-response relationships for both efficacy and side effects were established.

    • Conclusions:

    • Individualized dosing is crucial for acitretin therapy due to patient variability in response and side effects.
    • A dose-escalation strategy, starting low (10-25 mg/day) and increasing as tolerated, is recommended for optimal patient outcomes.